$0.0 (-1.28%)
Industry, Sector & symbol
Stock Exchange | New York Stock Exchange |
CEO | Dr. Shantanu K. Gaur M.D. |
Industry | Medical - Devices |
Sector | Healthcare |
Current Symbol | ALUR |
CUSIP | 02008G102 |
CIK | 0001964979 |
Web | https://www.allurion.com |
Phone | 508 647 4000 |
Currency | USD |
Employees | 501 |
Country | US |
Liquidity
Debt-to-Equity Ratio | -0.57 |
Payout Ratio | 0.00 |
Current Ratio | 2.33 |
Quick Ratio | 2.09 |
Cash Ratio | 1.49 |
Sales & Book Value
Annual Sales | $53.47M |
Price / Sales | 0.66 |
Cash Flow | -0.79 |
Price / Cash Flow | -0.45 |
Price / Book | -0.36 |
Price Target and Rating
Average Stock Price Forecast | $5.00 |
High Stock Price Forecast | $5.00 |
Low Stock Price Forecast | $5.00 |
Forecast Upside/Downside | -92.91% |
Consensus Rating | Sell |
Rating Score(0-5) | 2 |
Research Coverage | 2 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $-2.31 |
Trailing P/E Ratio | -0.92 |
PEG Ratio | -0.02 |
P/E Growth | -0.02 |
Net Income | $-82.3M |
Net Margin | -71.24% |
Pretax Margin | -70.14% |
Return on Equity | 36.54% |
Return on Assets | -48.84% |
Financials Score
AltmanZ Score | -5.85 |
Piotroski Score | 1.00 |
Working Capital | 25.58M |
Total Assets | 50.7M |
Ebit | -18.87M |
Market Cap | 22.85M |
Total Liabilities | 115.49M |
About Allurion Technologies Inc. (NYSE:ALUR) Stock
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. ...
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
2024-12-02 08:00:00
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock Exchange (the “NYSE”) stating that the NYSE has accepted the Company's previously submitted plan to regain compliance with the NYSE's continued listing standard set forth in Section 802.01B of the NYSE's Listed Company Manual (the “Minimum Market Capitalization Standard”.
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
2024-11-25 08:00:00
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the launch of AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss medications with the company's AI-native platform, featuring Coach Iris, to promote long-term weight maintenance, virtual access to dieticians and a connected smart scale measuring not just weight but muscle and bone mass. “Feedback from patients is clear; the.
Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
2024-11-13 12:43:56
Allurion Technologies Inc. (NYSE:ALUR ) Q3 2024 Earnings Conference Call November 13, 2024 8:30 AM ET Company Participants Mike Cavanaugh – Investor Relations Shantanu Gaur – Founder and Chief Executive Officer Brian Conyer – Vice President-Digital Health Adrian Wild – Senior Vice President-International Commercial Chris Geberth – Chief Financial Officer Conference Call Participants Josh Jennings – TD Cowen Matt Taylor – Jefferies Operator Thank you for standing by. My name is John, and I'll be your conference operator today.
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
2024-10-30 08:30:00
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (int.
ALUR Stock Declines Despite Submitting PMA for Allurion Balloon
2024-10-24 13:56:12
Allurion submits the first three modules of PMA application to the FDA for the Allurion Balloon.
Frequently Asked Questions
What is the current Allurion Technologies Inc. (ALUR) stock price?
Allurion Technologies Inc.(NYSE:ALUR) stock price is $0.3543 in the last trading session. During the trading session, ALUR stock reached the peak price of $4.0 while $0.31 was the lowest point it dropped to. The percentage change in ALUR stock occurred in the recent session was --1.28% while the dollar amount for the price change in ALUR stock was -$-0.0.
ALUR's industry and sector of operation?
The NYSE listed ALUR is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of ALUR?
Mr. Matt Wright
| Vice President of People
Dr. Shantanu K. Gaur M.D.
| Co-Founder, Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Mr. Ojas A. Buch
| Chief Operating Officer
Mr. Brendan Michael Gibbons J.D.
| Chief Legal Officer & Corporate Secretary
Dr. Samuel G. Levy
| Co-Founder
How many employees does ALUR have?
Number of ALUR employees currently stands at 501. ALUR operates from 11 Huron Drive, Natick, MA 01760, US.
Link for ALUR official website?
Official Website of ALUR is: https://www.allurion.com
How do I contact ALUR?
ALUR could be contacted at phone #508 647 4000 and can also be accessed through its website. ALUR operates from 11 Huron Drive, Natick, MA 01760, US.
How many shares of ALUR are traded daily?
The average number of ALUR shares traded daily for last 3 months was 376.48K.
What is the market cap of ALUR currently?
The market value of ALUR currently stands at $22.85M with its latest stock price at $0.3543